Form 8-K ENVIVIO INC For: Sep 03
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140903/AP2LD22FZW2ROTZ2222L2ZXQAMQGZZ223262
Filed on: September 3, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
- Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
- Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
